Reported about 16 hours ago
The pharmaceutical industry warns that President Trump's new drug pricing plan could lead to a $1 trillion loss for drug companies over the next decade. The proposal, which links Medicaid drug prices to those in other countries, has sparked significant lobbying efforts from the industry as executives prepare to push against it on Capitol Hill. Critics argue that the plan will harm American patients and innovative small biotech firms.
Source: YAHOO